0001711459-18-000001.txt : 20180202 0001711459-18-000001.hdr.sgml : 20180202 20180202132625 ACCESSION NUMBER: 0001711459-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180202 DATE AS OF CHANGE: 20180202 EFFECTIVENESS DATE: 20180202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prellis Biologics, Inc CENTRAL INDEX KEY: 0001711459 IRS NUMBER: 815455517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304720 FILM NUMBER: 18569785 BUSINESS ADDRESS: STREET 1: 479 JESSIE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 742-1283 MAIL ADDRESS: STREET 1: 479 JESSIE STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001711459 Prellis Biologics, Inc 953 Indiana Street SAN FRANCISCO CA CALIFORNIA 94107 (415) 742-1283 DELAWARE None None Corporation true 2017 Melanie Matheu 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Noelle Mullin 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Rohit Sharma 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Arvind Gupta 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b false 2018-01-22 false true true Preferred stock and common stock issuable upon conversion of the convertible equity instrument. false 0 1000000 460000 540000 false 2 0 0 0 false Prellis Biologics, Inc /s/ Noelle Mullin Noelle Mullin Chief Scientific Officer 2018-01-22